These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27109641)

  • 1. T cells and IL-17 in lupus nephritis.
    Koga T; Ichinose K; Tsokos GC
    Clin Immunol; 2017 Dec; 185():95-99. PubMed ID: 27109641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17-producing T cells in lupus nephritis.
    Apostolidis SA; Crispín JC; Tsokos GC
    Lupus; 2011 Feb; 20(2):120-4. PubMed ID: 21303828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
    AlFadhli S; AlFailakawi A; Ghanem AA
    Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative transcriptome analysis reveals a potential role for CaMK4 in γδT17 cells from systemic lupus erythematosus patients with lupus nephritis.
    Du B; Fan X; Lei F; Zhang S; Li G; Xi X
    Int Immunopharmacol; 2020 Mar; 80():106139. PubMed ID: 31978801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CaMK4 in immune responses.
    Koga T; Kawakami A
    Mod Rheumatol; 2018 Mar; 28(2):211-214. PubMed ID: 29252071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.
    Selvaraja M; Abdullah M; Arip M; Chin VK; Shah A; Amin Nordin S
    PLoS One; 2019; 14(11):e0224707. PubMed ID: 31697750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.
    Halfon M; Tankeu AT; Ribi C
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17 promotes murine lupus.
    Amarilyo G; Lourenço EV; Shi FD; La Cava A
    J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal-infiltrating CD11c
    Liao X; Ren J; Reihl A; Pirapakaran T; Sreekumar B; Cecere TE; Reilly CM; Luo XM
    Clin Exp Immunol; 2017 Nov; 190(2):187-200. PubMed ID: 28722110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
    Qi S; Chen Q; Xu D; Xie N; Dai Y
    Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
    Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
    Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus.
    Koga T; Ichinose K; Kawakami A; Tsokos GC
    Front Immunol; 2020; 11():624971. PubMed ID: 33597953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies targeting circulating protective molecules in lupus nephritis: Interest as serological biomarkers.
    Dumestre-Pérard C; Clavarino G; Colliard S; Cesbron JY; Thielens NM
    Autoimmun Rev; 2018 Sep; 17(9):890-899. PubMed ID: 30009962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
    Lourenço EV; Wong M; Hahn BH; Palma-Diaz MF; Skaggs BJ
    Arthritis Rheumatol; 2014 Mar; 66(3):674-85. PubMed ID: 24574228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17-producing T cells in lupus.
    Crispín JC; Tsokos GC
    Curr Opin Rheumatol; 2010 Sep; 22(5):499-503. PubMed ID: 20592603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis.
    Chen DY; Chen YM; Wen MC; Hsieh TY; Hung WT; Lan JL
    Lupus; 2012 Nov; 21(13):1385-96. PubMed ID: 22892208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The star target in SLE: IL-17.
    Yang Y; Yan C; Yu L; Zhang X; Shang J; Fan J; Zhang R; Ren J; Duan X
    Inflamm Res; 2023 Feb; 72(2):313-328. PubMed ID: 36538077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.